VRCA — Verrica Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Verrica Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	65.5	70.4	34.3	69.5	46.3
Net Total Accounts Receivable
Net Total Receivables	—	—	0.487	4.42	0.077
Total Inventory
Prepaid Expenses
Total Current Assets	67.7	74.3	39.1	77.5	51.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.94	5.5	5.33	3.62	2.58
Other Long Term Assets
Total Assets	74.2	80.1	44.7	81.6	54.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39.5	46.1	3.46	17	29
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	41.2	47.5	4.69	61.8	64
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	33	32.6	40	19.8	-9.86
Total Liabilities & Shareholders' Equity	74.2	80.1	44.7	81.6	54.1
Total Common Shares Outstanding